Understanding Immunotherapy

Value in Cancer Care

Alexander Bastian discusses the critical nature of value and cost-effectiveness in cancer care, which he says is a difficult challenge and must include patients and providers.

The Greatest Challenges in Incorporating Biomarkers into Cancer Care

Dr David Spigel discusses challenges and solutions to incorporating cancer biomarkers into patient care, including finding pathology resources to do the testing, issues around reimbursement, and educating colleagues on the value and operational aspects of biomarker testing in delivering personalized therapy to patients with cancer.